Jakub Kucharz
Krakow Branch
Krakow, MA, Poland
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.
Journal: Expert opinion on biological therapy
Published: August 29, 2026
Real-world comparison of the effectiveness and safety of immune-based combinations in elderly patients with advanced renal cell carcinoma (ARON-1 study).
Journal: Minerva urology and nephrology
Published: April 23, 2026
Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1).
Journal: Frontiers in immunology
Published: February 05, 2026
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group.
Journal: Expert opinion on pharmacotherapy
Published: February 04, 2026
Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project.
Journal: Clinical and experimental medicine
Published: November 25, 2025
Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV).
Journal: Cancer immunology, immunotherapy : CII
Published: August 26, 2025
Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.
Journal: Cancer immunology, immunotherapy : CII
Published: July 05, 2025
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study.
Journal: Clinical & experimental metastasis
Published: May 24, 2025
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study).
Journal: International journal of cancer
Published: April 10, 2025
Salvage chemotherapy in the intensive care unit: a case report of successful treatment of a critically ill patient with metastatic testicular germ cell tumor.
Journal: Frontiers in medicine
Published: March 24, 2025
Cabozantinib in the First-Line Treatment of Patients With Metastatic Renal Cell Carcinoma, Real-World Data From the Czech Republic and Poland: ICARO-RC Project.
Journal: Clinical genitourinary cancer
Published: March 06, 2025
Last Updated: 09/26/2026